Addus HomeCare (ADUS) Projected to Announce Earnings on Tuesday

Addus HomeCare (NASDAQ:ADUS) is projected to issue its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect the company to post earnings of $1.79 per share and revenue of $388.72 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 9:00 AM ET.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the firm earned $1.49 earnings per share. On average, analysts expect Addus HomeCare to post $6.33 EPS for the current fiscal year and $6.78 EPS for the next fiscal year.

Addus HomeCare Stock Down 0.5%

NASDAQ:ADUS opened at $121.17 on Tuesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 21.26, a price-to-earnings-growth ratio of 1.73 and a beta of 0.83. Addus HomeCare has a one year low of $87.95 and a one year high of $124.43. The stock has a 50-day simple moving average of $116.61 and a 200 day simple moving average of $106.22.

Analysts Set New Price Targets

ADUS has been the topic of several research reports. Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Raymond James Financial set a $137.00 target price on Addus HomeCare in a research report on Monday, September 28th. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Citigroup lowered Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Finally, Bank of America restated a “neutral” rating and set a $125.00 price objective (down from $140.00) on shares of Addus HomeCare in a research note on Monday, September 14th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus target price of $129.33.

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.